HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesAzvudine
Chemical structure of CAS 1011529-10-4

Azvudine

CAS No.1011529-10-4
MDL No.N/A
MFC9H11FN6O4
MW286.22
InChI KeyKTOLOIKYVCHRJW-XZMZPDFPSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1011529-10-4
Product NameAzvudine

Associated Conditions

COVID-19
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Lessons learnt from broad-spectrum coronavirus antiviral drug discovery.

Expert opinion on drug discovery • Vol. 19, Issue 9 • 2024
PMID: 39078037PMC: PMC11390334DOI: 10.1080/17460441.2024.2385598

Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients.

Signal transduction and targeted therapy • Vol. 6, Issue 1 • 2021
PMID: 34873151PMC: PMC8646019DOI: 10.1038/s41392-021-00835-6

Mechanistic Insight into Antiretroviral Potency of 2'-Deoxy-2'-β-fluoro-4'-azidocytidine (FNC) with a Long-Lasting Effect on HIV-1 Prevention.

Journal of medicinal chemistry • Vol. 63, Issue 15 • 2020
PMID: 32678592DOI: 10.1021/acs.jmedchem.0c00940

Synthesis of new 2'-deoxy-2'-fluoro-4'-azido nucleoside analogues as potent anti-HIV agents.

European journal of medicinal chemistry • Vol. 46, Issue 9 • 2011
PMID: 21745701PMC: PMC3164908DOI: 10.1016/j.ejmech.2011.06.020

Documentation

Similar Products